White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 6, 2004, Pages 822-827

  Capizzano, A A ^a   Acion L ^b   Bekinschtein, T ^c   Furman, M ^d   Gomila, H ^e   Martines A ^c   Mizrahi, R ^f   Starkstein, S E ^g  

^a HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^b UNIVERSITY OF IOWA   (United States)

^c Movement Disorders Section   (Argentina)

^d Argentine Sec of Sci and Technol   (Argentina)

^e Buenos Aires Neuropsychiatric Center   (Argentina)

^f UNIVERSITY OF TORONTO   (Canada)

^g FREMANTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX ATROPHY; BRAIN SIZE; CEREBROSPINAL FLUID; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; WHITE MATTER;

AGED; ALZHEIMER DISEASE; AMBULATORY CARE; ATROPHY; BRAIN; CEREBRAL CORTEX; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 2442651620     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.019273     Document Type: Article

References (45)

1. Hachinsky V, Potter P, Merksey H. Leuko-Araiosis. Arch Neurol 1987;44:21-3.
2. Longstheth WT, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular study. Stroke 1996;27:1274-82.
3. Boone KB, Miller BL, Lesser IM, et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. Arch Neurol 1992;49:549-54.
4. De Carli C, Murphy DGM, Tranh M, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy subjects. Neurology 1995;45:2077-84.
5. Bondareff W, Raval J, Woo B, et al. Magnetic resonance imaging and the severity of dementia in older adults. Arch Gen Psychiatry 1990;47:47-51.
6. Liu CK, Miller BL, Cummings JL, et al. A quantitative MRI study of vascular dementia. Neurology 1992;42:138-43.
7. Stout JC, Jernigan TL, Archibald SL, et al. Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. Arch Neurol 1996;53:742-9.
8. Giubilei F, Bastianello S, Paolillo A, et al. Quantitative magnetic resonance analysis in vascular dementia. J Neurol 1997;244:246-51.
9. Tanabe J, Amend D, Schuff N, et al. Tissue segmentation of the brain in Alzheimer's disease. AJNR Am J Neuroradiol 1997;18:115-23.
10. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999;67:66-72.
11. Libon DJ, Bogdanoff B, Cloud BS, et al. Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer's disease and ischaemic vascular dementia. J Clin Exp Neuropsychol 1998;20:30-41.
12. Starkstein SE, Sabe L, Vazquez S, et al. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1997;63:66-72.
13. Scheltens P, Erkinjunti T, Leys D, et al. White matter changes on CT and MRI: An overview of visual rating scales. Eur Neurol 1998;39:80-9.
14. Scheltens Ph, Barkhof F, Leys D, et al. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995;45:883-8.
15. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683-9.
16. Brun A, Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology 1981;5:549-64.
17. Englund E, Brun A, Alling C. White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain 1988;111:1425-1439.
18. Folstein MF, Folstein SE, McHugh PR. "Mini mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
19. Hughes CP, Berg L, Danziger W, et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-72.
20. Fahn S, Elton E. UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Mardsen CD, Goldstein M, Calne CD, eds. Recent developments in Parkinson's disease. Florham Park, NJ, Macmillan, 1987:153-63.
21. De Renzi E, Faglioni P. Development of a shortened version of the token test. Cortex 1978;14:41-9.
22. Kaplan EF, Goodglass H, Weintraub S. The Boston naming test. Philadelphia: Lea and Febiger, 1983.
23. Lezak MD. Neuropsychological assessment, 2nd edn. New York: Oxford University Press 1983.
24. Bushke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974;24:1019-25.
25. Andreasen NC, Rajarethinam R, Cizadlo T, et al. Automatic atlas-based volume estimation of human brain regions from MR images. J Comput Assist Tomogr 1996;20:98-106.
26. Harris G, Andreasen NC, Cizadlo T, et al. Improving tissue classification in MRI: A three-dimensional multispectral discriminant analysis method with automated training class selection. J Comput Assist Tomogr 1999;23:144-54.
27. Scheltens Ph, Barkhof F, Valk J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease: Evidence for heterogeneity. Brain 1992;115:735-48.
28. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNRAm J Neuroradiol 1987;8:421-6.
29. Leys D, Soetaert G, Petit H, et al. Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Arch Neurol 1990;47:524-7.
30. Miller DS, Kumar A, Yousem DM, et al. MRI high-intensity signals in late-life depression and Alzheimer's disease. Am J Geriatr Psychiatry 1994;2:332-7.
31. Fein G, Di Sclafani V, Tanabe J, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626-35.
32. Ishii N, Nishihara Y, Imamura T. Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 1986;36:340-5.
33. Starkstein SE, Sabe L, Vazquez S, et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke 1996;27:408-14.
34. Yamauchi H, Fukuyama H, Shio H. Corpus callosum atrophy in patients with leukoaraiosis may indicate global cognitive impairment. Stroke 2000;31:1515-20.
35. Facio EJ, Vega MG, Saggese JA. Estudio anatomopatológico de la sustancia blanca periventricular en condiciones normales y patológicas. In: Enrique José Facio. Neuropatología. Recopilación de su obra publicada. Buenos Aires: Asociación de Profesionales de Salud Mental del Hospital JT Borda, 1998.
36. Brun A. Englund E. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study, Ann Neurol 1986;19:253-62.
37. Inzitari D. Age related white matter changes and cognitive impairment. Ann Neurol 2000;47:141-3.
38. Sultzer DL, Mahler ME, Cummings JL, et al. Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and positron emission tomography findings. Arch Neurol 1995;52:773-80.
39. Mielke R, Herholz K, Grond M, et al. Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 1992;49:909-13.
40. 1H MR spectroscopy. AJNR Am J Neuroradiol 2000;21:621-30.
41. Smith CD, Snowdon DA, Wang H, et al. White matter volumes and periventricular white matter hyperintensities in aging and dementia. Neurology 2000;54:838-42.
42. Hampel H, Teipel SJ, Alexander GE, et al. Corpus callosum atrophy is a possible indicator of region and cell type specific neuronal degeneration in Alzheimer disease. Arch Neurol 1998;55:193-8.
43. Tsiskaridze A, Shakarishvili R, Janelidze M, et al. Cognitive correlates of leukoaraiosis in the early stages of Alzheimer's disease. Funct Neurol 1998;13:17-25.
44. Swan GE, DeCarli C, Miller BL, et al. Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology 2000;54:2108-14.
45. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145-51.